MTOR and breast cancer: In addition, treatment of 5–30 mM of MET on preheated (42°C) MCF-7 and MDA-MB-231 BC cells was observed to phosphorylate AMPK and reduce the phosphorylation of mTOR, thus reducing the activation of mTOR [32].